US20160096901A1 - Anti-cd38 human antibodies and uses thereof - Google Patents

Anti-cd38 human antibodies and uses thereof Download PDF

Info

Publication number
US20160096901A1
US20160096901A1 US14/958,959 US201514958959A US2016096901A1 US 20160096901 A1 US20160096901 A1 US 20160096901A1 US 201514958959 A US201514958959 A US 201514958959A US 2016096901 A1 US2016096901 A1 US 2016096901A1
Authority
US
United States
Prior art keywords
antibody
cd38
seq id
amino acids
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US14/958,959
Inventor
Michael Tesar
Ute Jaeger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morphosys AG
Original Assignee
Morphosys AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US54191104P priority Critical
Priority to US54758404P priority
Priority to US55394804P priority
Priority to US59901404P priority
Priority to US61447104P priority
Priority to US10/588,568 priority patent/US8263746B2/en
Priority to PCT/IB2005/002476 priority patent/WO2005103083A2/en
Priority to US13/427,305 priority patent/US20120189622A1/en
Priority to US14/630,042 priority patent/US20150232571A1/en
Application filed by Morphosys AG filed Critical Morphosys AG
Priority to US14/958,959 priority patent/US20160096901A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35197540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20160096901(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of US20160096901A1 publication Critical patent/US20160096901A1/en
Assigned to MORPHOSYS AG reassignment MORPHOSYS AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TESAR, MICHAEL, Jäger, Ute
Application status is Pending legal-status Critical

Links